The special drug use-results survey (All-Case Surveillance) of OfevĀ® Capsules in patients with Idiopathic Pulmonary Fibrosis (IPF) in Japan

08/09/2015
21/10/2026
EU PAS number:
EUPAS10891
Study
Finalised
Documents
Study protocol
Initial protocol
English (494.09 KB - PDF) View document
Study results
No information provided.
Study report
Study report
English (111.18 KB - PDF) View document
ENCePP Seal
No information provided.